Boundless Bio, Inc. (BOLD) Dividend History

Boundless Bio, Inc. (BOLD) is a biotechnology company focused on developing targeted therapies for cancer and other parts of the immune system. The company leverages its proprietary platforms to identify and develop innovative treatments aimed at addressing unmet medical needs.

9880 Campus Point Drive, San Diego, CA, 92121
Phone: (858) 766-9912
Website: https://www.boundlessbio.com

Dividend History

Boundless Bio, Inc. currently does not pay dividends

Company News

Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights

Boundless Bio, a clinical-stage oncology company, reported its Q1 2025 financial results and provided updates on its pipeline. The company has a cash position of $138.3 million, which is expected to fund operations into 2027. Boundless Bio is advancing its BBI-355 program, a CHK1 inhibitor, and its novel Kinesin program, with key milestones expected in 2025 and 2026.

GlobeNewswire Inc.
Wall Street Breakfast: The Week Ahead

Stay updated with the latest financial news and market trends by listening to the Wall Street Breakfast podcast available on Seeking Alpha, iTunes, and...

Seeking Alpha

Featured Companies: ABBV ACI BA BYND CART CAT CL CMCSA CMG CPNG CPRI CVX F GD GM GOOG GOOGL HLT IBM INTC LMT MAT META MMA MO MRK MSFT NVDA PEP PERI PM RILY SMMT SNAP SUN T TFC TPR TSLA TXN UBXG UPS URBN V VZ XOM

Page data last updated 07/23/2025 08:05:58 UTC